Baidu
map

EuroPCR2018丨临界冠脉狭窄患者易损斑块OCT特征的临床结局

2018-05-27 国际循环编辑部 国际循环

既往研究显示,某些光学相干断层扫描(OCT)特征如薄纤维帽粥样斑块(TCFA)可增加不良事件发生率。EuroPCR 2018大会上,波兰华沙医科大学 TOMANIAK M.等研究者发表一项最新研究结果,旨在确定在经血流储备分数(FFR)证实不明显的、血管造影所示的临界冠状动脉病变患者易损斑块OCT特征与随访1年临床结局的相关性。

既往研究显示,某些光学相干断层扫描(OCT)特征如薄纤维帽粥样斑块(TCFA)可增加不良事件发生率。EuroPCR 2018大会上,波兰华沙医科大学 TOMANIAK M.等研究者发表一项最新研究结果,旨在确定在经血流储备分数(FFR)证实不明显的、血管造影所示的临界冠状动脉病变患者易损斑块OCT特征与随访1年临床结局的相关性。(摘要号:Euro18A-OP141)

该单中心、单组研究共计连续入选124例血管造影存在临界冠状动脉狭窄的患者(涉及124处病变),采用OCT及FFR对其进行评估。了解易损斑块特征如TCFA即纤维帽最薄处<65 µm的情况,若FFR为70%或是直径狭窄超过50%且临床或超声心动图提示有心肌缺血改变则视为狭窄具有明显血流动力学意义。研究主要终点是不良心血管事件(MACE,即心源性死亡、Q波或非Q波型再梗死、紧急搭桥手术或临床驱动的TLR的复合终点)。分析显示,67处(54.0%)病变经FFR评估对血流动力学有显著影响。进一步分析发现,FFR评估存在及不存在明显血流动力学问题的患者中,分别有12例(17.9%)和10例(17.5%)患者存在TCFA(P=0.938)。进一步分析发现,上述两组患者的平均纤维帽厚度(0.09±0.04 mm vs. 0.15±0.09 mm,P=0.190)、纤维帽最薄厚度[(0.09±0.04)mm vs.(0.15±0.09)mm,P=0.197]、坏死核心[(148.4±72.2) vs.(94.4±41.6),P=0.010]及钙化纤维帽厚度[(0.09±0.06)mm vs.(0.14±0.11 mm),P=0.168]均无差异。

该研究结果表明,FFR显示存在及不存在明显血流动力学异常的患者的病变形态并无明显差异,是否存在OCT所示易损斑块特征患者的1年临床结局对比结果,将在本届大会发布。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2019-04-18 habb
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2019-02-02 tomyang98
  5. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-29 Tommy1950
  7. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-28 cxg966504

    学习了.感谢分享.

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-28 cxg966504

    感谢分享.

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-27 131****2916

    不错的文章值得学习到了.

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1843168, encodeId=d48e18431683d, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Sun Mar 31 02:33:00 CST 2019, time=2019-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858326, encodeId=d63a185832615, content=<a href='/topic/show?id=21311323521' target=_blank style='color:#2F92EE;'>#OCT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13235, encryptionId=21311323521, topicName=OCT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 18 20:33:00 CST 2019, time=2019-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778538, encodeId=3b0f1e7853833, content=<a href='/topic/show?id=34a6309846f' target=_blank style='color:#2F92EE;'>#冠脉狭窄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30984, encryptionId=34a6309846f, topicName=冠脉狭窄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d839300933, createdName=wleon8908, createdTime=Thu Jul 19 07:33:00 CST 2018, time=2018-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746880, encodeId=eec21e46880d4, content=<a href='/topic/show?id=1fb7e08974' target=_blank style='color:#2F92EE;'>#EuroPCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7089, encryptionId=1fb7e08974, topicName=EuroPCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b4735868574, createdName=tomyang98, createdTime=Sat Feb 02 06:33:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1330083, encodeId=f2dd1330083d8, content=<a href='/topic/show?id=a91c5e92328' target=_blank style='color:#2F92EE;'>#斑块#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57923, encryptionId=a91c5e92328, topicName=斑块)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419411, encodeId=79451419411b4, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Tue May 29 12:33:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319176, encodeId=8da73191e65c, content=学习了.感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:16:10 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319175, encodeId=e0b63191e5a6, content=感谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/28/7730a2ceddef8c4a7b8f726be3f9e566.jpg, createdBy=ec271557270, createdName=cxg966504, createdTime=Mon May 28 00:15:49 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319159, encodeId=434c3191590f, content=不错的文章值得学习到了., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sun May 27 22:58:07 CST 2018, time=2018-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=319138, encodeId=9258319138c7, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sun May 27 22:10:33 CST 2018, time=2018-05-27, status=1, ipAttribution=)]
    2018-05-27 changjiu

    学习一下谢谢

    0

相关资讯

JAMA Intern Med:国内冠状动脉狭窄严重程度诊断准确性有待提升

研究发现,对于接受PCI治疗的中国冠状动脉病变患者,医师视觉评估对动脉狭窄严重程度的评估普遍高于冠脉造影定量分析,其差异随不同医院和医生的变化而变化,提高中国冠状动脉狭窄严重程度诊断的准确性十分必要

GW-ICC 2016:ACC联合专场——老年心脏病与心脏影像学进展

程标教授在会场讲课当前社会,我国已经进入人口老龄化快速发展阶段。2013年我国老年人口数量已达2.02亿,人口老龄化水平达到14.9%。据预测,2050年我国老年人口数量将达到4.8亿。人口老龄化所带来的老年人口健康问题已成为影响我国经济社会发展的重要公共卫生问题,其中心血管疾病尤为严峻。今天上午的ACC@GW-ICC联合论坛以“老年心脏病学:我们准备好迎接浪潮了吗”为主题,多位国内外专家做了精彩

Lancet:治疗冠状动脉狭窄,选择依维莫司生物可吸收支架还是金属支架?

依维莫司洗脱生物可吸收血管支架和依维莫司洗脱支架效果的随机比较还没有可用的中期数据。

Baidu
map
Baidu
map
Baidu
map